Status:
RECRUITING
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Metabolic Dysfunction Associated Steatohepatitis (MASH)
Liver Fibrosis
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This study is open to adults who are at least 18 years old living with obesity and have: * a confirmed liver disease called non-alcoholic steatohepatitis (NASH)/metabolic associated steatohepatitis (...
Eligibility Criteria
No eligibility criteria provided.
Key Trial Info
Start Date :
September 17 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 27 2031
Estimated Enrollment :
1800 Patients enrolled
Trial Details
Trial ID
NCT06632444
Start Date
September 17 2024
End Date
December 27 2031
Last Update
March 6 2026
Active Locations (518)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35233
2
The Institute for Liver Health II DBA Arizona Clinical Trials
Peoria, Arizona, United States, 85381
3
Scottsdale Medical Specialists, Ltd
Scottsdale, Arizona, United States, 85260
4
Adobe Clinical Research, LLC
Tucson, Arizona, United States, 85712